Sponsored by:

Nuclear Medicine: Page 330

Siemens wins mobile PET/CT contract
By AuntMinnie.com staff writers
Siemens Medical Solutions of Malvern, PA, has installed the first of four Biograph 6 TruePoint PET/CT systems into mobile vehicles operated by InHealth Molecular Imaging Solutions.
February 20, 2008
Part I: Stroke imaging hones in on preventable infarction
By Eric Barnes
Our two-part series on acute stroke imaging presents current controversies in the field and the views of leading stroke researchers in neurology and radiology. Part I looks at image-guided treatment of at-risk brain tissue, patient selection, and study design.
February 20, 2008
2008 02 21 15 43 01 706
MR-IMPACT trial: CMR equivalent to SPECT for stenosis detection
By Eric Barnes
In a prospective, randomized trial conducted at 18 sites internationally, MR first-pass myocardial perfusion imaging (perfusion-CMR) was at least equivalent to SPECT for detecting coronary artery stenosis, according to a new report in the European Heart Journal.
February 17, 2008
Siemens responds to FDA warning letter
By AuntMinnie.com staff writers
Siemens Medical Solutions' molecular imaging division has received a warning letter from the U.S. Food and Drug Administration (FDA) regarding the company's molecular imaging equipment, specifically the company's ECAT PET scanner.
February 14, 2008
Study reinforces V/Q, PIOPED II guidelines for PE during pregnancy
By Cynthia E. Keen
The results of an analysis of ventilation/perfusion (V/Q) scans performed over a seven-year period reinforce the recommendations of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) II trial. The V/Q scan remains an excellent study to make or rule out the diagnosis of pulmonary embolism in pregnant women, according to researchers from Rhode Island.
February 14, 2008
Dilon taps Moussa as CEO
By AuntMinnie.com staff writers
Scintimammography developer Dilon Technologies has appointed Robert Moussa as president and CEO.
February 11, 2008
GE inks New York pact
By AuntMinnie.com staff writers
GE Healthcare of Chalfont St. Giles, U.K., has signed a $4.4 million contract to supply IT products and a PET/CT scanner to ProHealth Care Associates.
February 10, 2008
Chalk River shutdown hurts Draxis' results
By AuntMinnie.com staff writers
Lower product sales in its radiopharmaceutical business combined with the stronger Canadian dollar to depress revenues at Canadian radiopharmaceutical developer Draxis Health of Montreal in 2007.
February 7, 2008
NRC investigates Covidien production issue
By AuntMinnie.com staff writers
The U.S. Nuclear Regulatory Commission (NRC) said it is working with Mallinckrodt, a division of Covidien of Hamilton, Bermuda, to investigate elevated levels of molybdenum-99 in the company's technetium-99m isotope.
February 7, 2008
Digirad revenues edge up, loss narrows
By AuntMinnie.com staff writers
Nuclear medicine firm Digirad of Poway, CA, turned in stronger financial results based on higher annual revenues and decreased operating expenses for 2007.
February 6, 2008
PharmaLogic P.E.T. Services receives PET nod
By AuntMinnie.com staff writers
PharmaLogic P.E.T. Services of Montreal has received approval from the Canadian government to begin selling its formulation of FDG.
February 3, 2008
False positives a concern with FDG-PET/CT for head, neck tumors
By Wayne Forrest
FDG-PET/CT is worthwhile for assessing patients with occult head and neck primary tumors, but false positives remain a shortcoming of the hybrid technology, according to a British study. The results show that FDG-PET/CT cannot replace examination under anesthesia and biopsies for assessing occult head and neck primary tumors.
January 30, 2008
2008 01 30 16 13 57 706
Previous Page
Page 330 of 440
Next Page